Risk of Upper Gastrointestinal Complications Among Users of Traditional NSAIDs and COXIBs in the General Population
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 132 (2) , 498-506
- https://doi.org/10.1053/j.gastro.2006.12.007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial InfarctionBasic & Clinical Pharmacology & Toxicology, 2006
- Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunitiesJournal of Clinical Investigation, 2005
- Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance DatabaseEuropean Journal of Clinical Pharmacology, 2004
- COX‐2‐selective inhibitors and the risk of upper gastrointestinal bleeding in high‐risk patients with previous gastrointestinal diseases: a population‐based case–control studyAlimentary Pharmacology & Therapeutics, 2004
- Upper Gastrointestinal Bleeding Associated with the Use of NSAIDsDrug Safety, 2004
- Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugsBMJ, 2002
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Association Between Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Tract Bleeding/PerforationArchives of internal medicine (1960), 2000
- Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory DrugsAnnals of Internal Medicine, 1991